Scancell higher as it is to begin UK arm of phase II skin cancer trial within weeks
The mid-stage study is testing Scancell’s flagship skin cancer immunotherapy in combination with Keytruda – the blockbuster checkpoint inhibitor developed by Merck
Company
Scancell Holdings PLC
LON:SCLP
Scancell is a clinical stage biotech company developing immunotherapies for a cancer-free future by enhancing long-lasting tumour specific immunity. With deep roots in cancer immunology and translational research, the company aims to translate its innovation and creativity to address the need for fast, potent and accessible therapies that are easy to administer in hard-to-treat cancers.
329 stories · page 9 of 17
Archive
Proactive news snapshot: Anglo Asian Mining, Scancell, Circle Property …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Totally jumps as healthcare provider flags contract awards in upbeat trading statement
A look at some of the day's major movers, including Totally, Ascent Resources , Firestone Diamonds, Adept4, LightwaveRF and Adept4
Scancell Holdings wins Japanese patent protection
It follows on from similar awards in key markets such as the US, Europe, South Africa and Australia
Investments and investor services
WH Ireland claws back some recent losses as shareholders OK fund-raising
A look at the day's major movers, including Cadence Minerals, FW Thorpe, IG Group, LPA, Integrated Diagnostics, Wynnstay and Clear Leisure
Archive
Proactive news snapshot: ValiRx, LoopUp Group, Kibo Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
FTSE 100 closes higher at traders focus on Federal Reserve's dovish tone
The FTSE 250 though, seen as a better indicator of the state of UK companies, closed down around 41 points at 19,347.
Archive
Proactive news snapshot: Motif Bio, Bluejay Mining, 88 Energy, Scancell …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
SimplyBiz boosted by agreement to acquire financial adviser Defaqto
A look at the day's biggest risers and fallers including SimplyBiz, Motif Bio, and Amphion
Scancell strengthens IP with two “important” patent grants in US and Europe
The US patent covers Modi-1, while the European patent relates to a monoclonal antibody called FG88
Archive
FTSE 100 closes firmly in red as traders flee risk ahead of Fed statement
The UK blue-chip index finished down nearly 33 points lower at 7,291
Archive
Proactive news snapshot: Faron Pharmaceuticals, Sunrise Resources, Tertiary Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
PCI-PAL surrenders some recent gains as half-year losses widen
A look at the day's major movers, including Gulf Marine Services, Argos Resources, Premier Technical Services, Serco, Vitec, Purplebricks and Centrica
Scancell in vanguard of immuno-oncology advances, with two technologies that show early promise
The AIM-listed group is at the vanguard of advances in the emerging field of immuno-oncology and is working on two technologies that are showing early promise
Investments and investor services
Philip Hammond’s online tax comments hit ASOS, BooHoo and JustEat
A look at some of the top risers and fallers in London today
Archive
Proactive news snapshot: Arix Bioscience, RM Secured Direct Lending, Diversified Gas & Oil …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
FTSE 100 set to end the week in volatility as metal tariffs hit Turkish lira
The quarterly update on the health of the UK economy showed something of a recovery from the snowed under first quarter.
Scancell Holdings part of the new cancer revolution
The AIM-listed drug developer is at the vanguard of advances in the emerging field of immuno-oncology
Investments and investor services
Ascent Resources doubles as it sees end to permitting delays
A look at some of the top risers and fallers in London today
Archive
Proactive news snapshot: Mirada, Touchstone Exploration, Seeing Machines …
A glance at some of the day's highlights from the Proactive Investors newswire